A

Atara Biotherapeutics
D

ATRA

7.83000
USD
0.15
(1.95%)
مغلق
حجم التداول
2,041
الربح لكل سهم
-9
العائد الربحي
-
P/E
-1
حجم السوق
45,875,257
أصول ذات صلة
C
CRVS
0.12000
(3.43%)
3.62000 USD
F
FATE
0.09000
(7.38%)
1.31000 USD
G
GLYC
0.00110
(0.42%)
0.26400 USD
R
RCKT
0.16000
(2.04%)
8.02000 USD
R
RGEN
4.530
(3.30%)
141.720 USD
T
TXG
0.35000
(4.33%)
8.43000 USD
V
VKTX
0.775
(2.71%)
29.360 USD
المزيد
الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).